Activated CD4 + T cells diff erentiate into at least three distinct eff ector subsets as defi ned by their patterns of cytokine production ( 1 -4 ) . Th1 cells produce IFN-␥ and lymphotoxin and play a critical role in protective immunity against intracellular pathogens ( 1 -4 ) . Th2 cells produce IL-4, -5, and -13 and are essential for the expulsion of parasites ( 1 -4 ) . Newly identifi ed Th17 cells produce IL-17A and -17F and play a pathogenic role in a variety of autoimmune diseases ( 1 -5 ) . Recently, it has been reported that IL-21 is another cytokine highly produced by Th17 cells and that it promotes the development of Th17 cells ( 6 -9 ) .
IL-21 is a four-helix-bundle type I cytokine with signifi cant homology to IL-2, -15, and -4 ( 10 -12 ) . IL-21 has been demonstrated to be expressed in Th2 cells ( 13 ) , follicular B helper T cells ( 14 ) , and NK T cells ( 15 ) and to exhibit pleiotropic eff ects on the proliferation, diff erentiation, and eff ector function of T, B, NK, and dendritic cells ( 10 -12 ) . In vivo, it has been shown that IL-21 is involved in several autoimmune disease models. For example, lymphopenia and compensatory IL-21 -mediated homeostatic expansion of lymphocytes has been reported to be involved in the development of autoimmunity in NOD mice ( 16 ) . The excessive production of IL-21 has been shown to be associated with the development of high titers of autoantibodies and a lupus-like pathology in Sanroque mice ( 17 ) . Furthermore, a blockade of IL-21 signaling has been demonstrated to ameliorate mouse models of rheumatoid arthritis and lupus ( 18, 19 ) . However, the characteristic of IL-21 -producing CD4 + T cells, especially in their relation to Th17 cells, is still unknown because a single-cell analysis of IL-21 -producing cells has not been achieved yet. IL-21 functions as an autocrine growth factor for Th17 cells ( 6 -9 ) . We also found that IL-21 was produced by activated CD4 + T cells under Th17-polarizing conditions (in the presence of IL-6, TGF-␤ , anti -IL-4 mAb, and anti -IFN-␥ mAb) much greater than under Th2-polarizing conditions or under Th1-polarizing conditions ( Fig. 1 A ) . However, it was still unclear whether IL-21 is actually produced by Th17 cells and what is the developmental and phenotypic characteristic of IL-21 -producing CD4 + T cells because IL-21 production has not been determined at single-cell levels as yet. To address these issues, we established the intracellular cytokine staining of IL-21. We fi rst generated several IL-21 -producing Ba/F3 cell clones using a bicistronic retrovirus system and measured the levels of IL-21 in the culture supernatants by ELISA. Among these clones, Ba/F3-IL-21-GFP #6 cells produced a signifi cant amount of IL-21 ( Fig. 1 B , left) , and we used this clone as a positive control for intracellular staining of IL-21. To detect intracellular IL-21, we used mouse IL-21R/human Fc-chimera (IL-21R-Fc) to capture IL-21 and anti -human Fc PE to visualize IL-21 -IL-21R-Fc complexes. When cells were stained by this method, positive signals were detected in Ba/F3-IL-21-GFP #6 cells, but not in control Ba/F3-empty-GFP cells ( Fig. 1 B , right) . In the absence of IL-21R-Fc, no positive signal was detected ( Fig. 1 B ,  right) , confi rming the correct detection of IL-21 by the intracellular staining.
By using the intracellular staining of IL-21, we examined IL-21 -producing CD4 + T cells at single-cell levels. When In this study, by establishing the intracellular staining of IL-21, we found that although IL-21 -producing CD4 + T cells developed preferentially under Th17-polarizing conditions, a considerable number of IL-21 -producing CD4 + T cells were negative for intracellular IL-17A and -17F. We also found that IL-6 potently induced the development of IL-21 -producing CD4 + T cells without the induction of IL-4, IFN-␥ , IL-17A, or IL-17F production. On the other hand, TGF-␤ inhibited the IL-6 -induced development of IL-21 -producing CD4 + T cells. In addition, IL-2 signifi cantly enhanced the development of IL-21 -producing CD4 + T cells under Th17-polarizing conditions. IL-21 itself also induced the development of IL-21 -producing CD4 + T cells. IL-21 -producing CD4 + T cells exhibited a stable phenotype of IL-21 production in the presence of IL-6, but still had a potential to produce IL-4 under Th2-polarizing conditions and IL-17A under Th17-polarizing conditions. Our results suggest that IL-21 -producing CD4 + T cells exhibit distinct characteristics from Th17 cells, that IL-21 -producing CD4 + T cells develop preferentially in an IL-6-rich environment devoid of TGF-␤ , and that IL-21 functions as an autocrine growth factor for IL-21 -producing CD4 + T cells.
RESULTS

IL-21 -producing CD4 + T cells develop preferentially
under Th17-polarizing conditions, but the majority of them are negative for intracellular IL-17A and -17F Recently, it has been shown that Th17 cells produce a large amount of IL-21 compared with Th2 and Th1 cells, and that ment of IL-21 -producing CD4 + T cells. Naive CD4 + T cells were stimulated with anti-CD3 mAb/anti-CD28 mAb in the presence of IL-6, anti -IL-4 mAb, and anti -IFN-␥ mAb with or without TGF-␤ . We found that IL-6 together with the blocking antibodies to IL-4 and IFN-␥ strongly induced the development of IL-21 -producing CD4 + T cells without the induction of IL-4, IFN-␥ , IL-17A, or IL-17F production ( Fig. 3 A ) . Furthermore, unexpectedly, TGF-␤ inhibited the development of IL-21 -producing CD4 + T cells in a dosedependent manner ( Fig. 3 A ) . Measurement of IL-21 levels in the supernatants confi rmed the TGF-␤ -mediated inhibition of IL-21 production ( Fig. 3 B ) . TGF-␤ also inhibited the development of IL-21 -producing CD4 + T cells under FACS-sorted naive CD4 + T cells (CD44 low CD25 Ϫ CD4 + T cells) were stimulated with anti-CD3 mAb/anti-CD28 mAb under Th1-, Th2-, and Th17-polarizing conditions, IL-21 -producing cells were detected under Th17-polarizing conditions with a high frequency and under Th2-polarizing conditions with a moderate frequency ( Fig. 2 ) , which is consistent with the levels of IL-21 in the supernatants of activated CD4 + T cells under the corresponding culture conditions ( Fig. 1 A ) . Under Th2-polarizing conditions, a signifi cant number of IL-4 -producing cells simultaneously produced IL-21 and > 70% of IL-21 -producing CD4 + T cells were positive for intracellular IL-4 ( Fig. 2 ) . Under Th17-polarizing conditions, a signifi cant number of IL-17A-and IL-17F -producing cells also simultaneously produced IL-21, but > 60% of IL-21 -producing CD4 + T cells were negative for intracellular IL-17A and -17F ( Fig. 2 ) . IL-21 -producing CD4 + T cells under Th17-polarizing conditions were also negative for intracellular IL-4 and IFN-␥ ( Fig. 2 ) . These results suggest that although IL-21 -producing CD4 + T cells develop preferentially under Th17-polarizing conditions, the majority of IL-21 -producing CD4 + T cells do not produce IL-17A or -17F.
IL-6 induces, but TGF-␤ inhibits, the development of IL-21 -producing CD4 + T cells
Because IL-21 -producing CD4 + T cells developed preferentially under Th17-polarizing conditions as compared with Th1-or Th2-polarizing conditions ( Fig. 1 A and Fig. 2 ), we next examined the role of IL-6 and TGF-␤ in the develop- ( 23, 24 ) . We then used the mice lacking Smad3 (Smad3 Ϫ / Ϫ mice) to determine whether Smad3 is required for the TGF-␤ -mediated suppression of IL-21 -producing CD4 + T cells. Purifi ed CD4 + T cells from WT mice or asymptomatic Smad3 Ϫ / Ϫ mice, in the latter of which lymph node CD4 + T cells exhibit a normal phenotype regarding the activation markers such as CD69 (unpublished data) ( 25 ) , were stimulated with anti-CD3 mAb/anti-CD28 mAb in the presence of IL-6, anti -IL-4 mAb, anti -IFN-␥ mAb, and anti -IL-2 mAb with or without TGF-␤ and the development of IL-21 -producing CD4 + T cells and Th17 cells was evaluated by intracellular staining. As shown in Fig. 5 , not only TGF-␤ -mediated induction of Th17 cell development but also TGF-␤ -mediated suppression of IL-21 -producing CD4 + T cells were reduced in Smad3 Ϫ / Ϫ CD4 + T cells compared with those in littermate WT mice. These results indicate that TGF-␤ signaling induces Th17 cell development, but inhibits the development of IL-21 -producing CD4 + T cells, in part via Smad3-dependent pathways.
Smad3 is involved in TGF-
IL-2 does not inhibit the development of IL-21 -producing CD4 + T cells
It has recently been reported that IL-2 signaling via STAT5 inhibits the development of Th17 cells ( 26 ) . We next examined the role of IL-2 in the development of IL-21 -producing CD4 + T cells. When naive CD4 + T cells were stimulated with anti-CD3 mAb/anti-CD28 mAb in the presence of IL-6, anti -IL-4 mAb, and anti -IFN-␥ mAb, neither IL-2 nor anti -IL-2 mAb signifi cantly aff ected the development of IL-21 -producing CD4 + T cells ( Fig. 6 ). On the other hand, Th2-polarizing conditions (unpublished data). In contrast, consistent with previous reports ( 20 -22 ) , TGF-␤ together with IL-6 induced the development of IL-17A -and IL-17F -producing Th17 cells ( Fig. 3 A ) . These results indicate that IL-6 induces the development of IL-21 -producing CD4 + T cells, but on the contrary, TGF-␤ inhibits IL-6 -induced development of IL-21 -producing CD4 + T cells.
We next examined the kinetics of IL-21, -17A, and -17F production from naive CD4 + T cells upon stimulation with anti-CD3 mAb/anti-CD28 mAb. In the presence of IL-6, anti -IL-4 mAb, and anti -IFN-␥ mAb, IL-21 -producing CD4 + T cells were detected at a low frequency at day 1 after stimulation, and then the frequency of IL-21 -producing CD4 + T cells was increased until day 4 in a time-dependent manner without the production of IL-17A and -17F ( Fig. 4 ) . Under Th17-polarizing conditions, IL-21 -producing CD4 + T cells were also detected at day 1, but the frequency of IL-21 -producing CD4 + T cells was not increased thereafter ( Fig. 4 ) . On the other hand, IL-17A -producing CD4 + T cells were detected at day 2 under Th17-polarizing conditions ( Fig. 4 ) . IL-17F -producing CD4 + T cells were also detected at day 2 under Th17-polarizing conditions and were increased at day 4 ( Fig. 4 ) . presence of IL-6, anti -IL-4 mAb, and anti -IFN-␥ mAb and under Th17-polarizing conditions by 20 -30% ( Fig. 7 B ) . These results suggest that IL-21 and -6 both induce the development of IL-21 -producing CD4 + T cells, the eff ect of the latter of which is mediated in part by IL-21 production.
In contrast, the blockade of IL-21 signaling by soluble IL-21R-Fc resulted in the decreased development of Th17 cells ( Fig. 7 B ) , which is consistent with previous reports ( 6 -9 ) . Together with our fi nding that a considerable number of IL-21 -producing CD4 + T cells are negative for intracellular IL-17A and -17F under Th17-polarizing conditions ( Fig. 2 ) , these results suggest that IL-21 functions not only as an autocrine growth factor but also as a paracrine growth factor for the development of Th17 cells.
We also examined the eff ect of anti -IL-6 antibody on the diff erentiation of IL-21 -producing CD4 + T cells from naive CD4 + T cells cultured under Th2-polarizing conditions. As shown in Fig. 7 C , a neutralizing antibody against IL-6 decreased the number of IL-21 -producing CD4 + T cells by 50% without any signifi cant change in the number of IL-4 single-positive cells. Moreover, although soluble IL-21R-Fc itself did not signifi cantly decrease the number of IL-21 -producing CD4 + T cells under Th2-polarizing conditions (unpublished data), IL-21R-Fc together with anti -IL-6 antibody signifi cantly suppressed the diff erentiation of IL-21 -producing CD4 + T cells under Th2-polarizing conditions to a greater extent than anti -IL-6 antibody alone ( Fig. 7 C ) . These results suggest that during Th2 cell diff erentiation, IL-6 produced by Th2 cells promotes the diff erentiation of IL-21 -producing CD4 + T cells from Th2 cells and non-Th2 CD4 + T cells.
Expression of transcription factors in CD4 + T cells cultured in the presence of IL-6
We also examined the expression pattern of transcription factors in CD4 + T cells that were cultured in the presence of IL-6, anti -IL-4 mAb, and anti -IFN-␥ mAb. Consistent with previous reports ( 5 ), CD4 + T cells cultured under Th17-polarizing conditions expressed ROR ␥ t, but not Foxp3, T-bet, or GATA3 ( Fig. 8 ) . In contrast, CD4 + T cells cultured in the presence of IL-6, anti -IL-4 mAb, and anti -IFN-␥ mAb expressed a moderate level of ROR ␥ t, but not Foxp3, T-bet, or GATA3 ( Fig. 8 ) . As expected, Th1 cells expressed T-bet, Th2 cells expressed GATA3, and regulatory T (T reg) cells expressed Foxp3 ( Fig. 8 ) .
The frequency of IL-21 -producing cells is increased with the rounds of cell cycle progression It has been shown that the production of cytokines such as IL-4 is correlatively increased in CD4 + T cells with cell divisions ( 27, 28 ) . We next examined the correlation of IL-21 production and cell cycle progression of CD4 + T cells using a CFSElabeling method. As shown in Fig. 9 , the frequency of cell division was indistinguishable in CD4 + T cells cultured in the presence of IL-6, anti -IL-4 mAb, and anti -IFN-␥ mAb and under Th17-polarizing conditions, IL-2 signifi cantly enhanced the development of IL-21 -producing CD4 + T cells ( Fig. 6 ) . In contrast, IL-17A -and IL-17F -producing CD4 + T cells were decreased by IL-2 and were increased by anti -IL-2 mAb under Th17-polarizing conditions ( Fig. 6 ) , which is consistent with the previous study showing that the genetic deletion or antibody blockade of IL-2 promotes the diff erentiation of IL-17A -producing CD4 + T cells ( 26 ) . These results suggest that, in contrast to the development of Th17 cells, IL-2 instead exerts an enhancing eff ect on the development of IL-21 -producing CD4 + T cells under Th17-polarizing conditions. ( Fig. 7 A ) . In addition, IL-21 -induced development of IL-21 -producing CD4 + T cells was inhibited by TGF-␤ ( Fig.  7 A ) , like IL-6 -induced development was ( Fig. 3 ) . Soluble IL-21R-Fc, which neutralizes IL-21 ( 10 ), also inhibited the development of IL-21 -producing CD4 + T cells both in the under Th17-polarizing conditions. IL-21 -producing CD4 + T cells were observed in all rounds of cell cycle progression in the presence of IL-6, anti -IL-4 mAb, and anti -IFN-␥ mAb, but the frequency of IL-21 -producing cells was increased with the rounds of cell cycle progression ( Fig. 9 ) . Similarly, under Th17-polarizing conditions, IL-17A -and IL-17F -producing cells were observed in all rounds of cell cycle progression, but the frequency of them was also increased with the rounds of cell cycle progression ( Fig. 9 ) .
IL-21 -producing CD4 + T cells do not lose the ability to produce IL-21 when they are restimulated under Th1-or Th2-polarizing conditions Fully diff erentiated Th1 cells and Th2 cells exhibit a stable phenotype regarding the pattern of cytokine production ( 29, 30 ) . Finally, we examined whether IL-21 -producing CD4 + T cells exhibited a stable phenotype of IL-21 production. To address this issue, CD4 + T cells were stimulated with anti-CD3 mAb/anti-CD28 mAb in the presence of IL-6, anti -IL-4 mAb, and anti -IFN-␥ mAb twice, at a 5-d interval, and IL-21 production was assessed by intracellular staining after restimulation with anti-CD3 mAb. As shown in Fig. 10 A (top), IL-21 -producing CD4 + T cells did not lose their ability to produce IL-21 at 10 d and did not produce a significant amount of IFN-␥ , IL-4, or IL-17A. This stable phenotype of IL-21 -producing CD4 + T cells was observed at least for 20 d of culture (unpublished data). We also examined whether IL-21 -producing CD4 + T cells exhibited a stable phenotype against Th1, Th2, or Th17 polarization. After CD4 + T cells were stimulated with anti-CD3 mAb/ anti-CD28 mAb in the presence of IL-6, anti -IL-4 mAb, and anti -IFN-␥ mAb for 5 d, these cells were restimulated under Th1-, Th2-, or Th17-polarizing conditions for 5 d. As shown in Fig. 10 A (bottom) , IL-21 -producing CD4 + T cells that were restimulated under Th1-polarizing conditions produced IL-21, but not IFN-␥ , indicating that IL-21 -producing CD4 + T cells are stable against Th1 polarization. In contrast, when IL-21 -producing CD4 + T cells were restimulated under Th2-polarizing conditions, a considerable population of cells produced both IL-21 and -4 ( Fig. 10 A ) , suggesting that IL-21 -producing CD4 + T cells may have a potential for IL-4 production. When IL-21 -producing CD4 + T cells were restimulated under Th17-polarizing conditions, IL-21 -producing CD4 + T cells were decreased and IL-17A -producing cells were increased ( Fig. 10 A ) , suggesting that IL-21 -producing CD4 + T cells may also have a potential for the diff erentiation of Th17 cells. Collectively, these results indicate that IL-21 -producing CD4 + T cells exhibit a stable phenotype of IL-21 production in the presence of IL-6, but may still have a potential for IL-4 and -17A production. 
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IL-21 was originally reported to be a product of activated CD4 + T cells ( 10 ) . Subsequently, it has been shown that among CD4 + T cells, Th2 cells but not Th1 cells produce IL-21 ( 13 ) . More recently, it has been demonstrated that Th17 cells produce higher levels of IL-21 than Th2 cells and that IL-21 functions as an autocrine growth factor for Th17 cells ( 6 -9 ) . However, all of these fi ndings were based on the analysis on a mixed population of CD4 + T cells because there has been no single-cell analysis for IL-21 production available as yet. In this study, we have established the intracellular cytokine staining of IL-21 and have shown that a considerable number of IL-21 -producing CD4 + T cells under Th17-polarizing conditions are negative for intracellular IL-17A and -17F ( Figs. 2 and 3 ) , providing a new insight into the cellular source of IL-21 in activated CD4 + T cells.
We show that IL-6 and -21 both potently induce the development of IL-21 -producing CD4 + T cells ( Figs. 3 and 7 ) . In addition, IL-6 -induced development of IL-21 -producing CD4 + T cells is mediated in part by IL-21 production because IL-6 -induced development of IL-21 -producing CD4 + T cells was modestly, but reproducibly, decreased by the neutralization of IL-21 ( Fig. 7 ) . In a preliminary study, we also found that IL-21 enhanced the survival of IL-21 -producing CD4 + T cells (unpublished data). These results suggest that IL-21 may function as an autocrine growth factor for IL-21 -producing CD4 + T cells. In contrast, because IL-21 induces Th17 cell development ( Fig. 7 A ) ( 6 -9 ) , and because a considerable number of IL-21 -producing CD4 + T cells
DISCUSSION
In this study, we investigated the diff erentiation and characteristics of IL-21 -producing CD4 + T cells. By the newly developed intracellular staining of IL-21, we found that although IL-21 -producing CD4 + T cells developed preferentially under Th17-polarizing conditions, a considerable number of IL-21 -producing CD4 + T cells were negative for intracellular IL-17A and -17F ( Fig. 2 ) . We also found that IL-6 strongly induced the development of IL-21 -producing CD4 + T cells without the induction of IL-4, IFN-␥ , IL-17A, and IL-17F production ( Fig. 3 ) . Furthermore, TGF-␤ inhibited the IL-6-induced development of IL-21 -producing CD4 + T cells in a dose-dependent manner ( Fig. 3 ) . In contrast, consistent with previous reports ( 20 -22 ) , TGF-␤ together with IL-6 induced the development of Th17 cells ( Fig. 3 ) . IL-21 itself also induced the development of IL-21 -producing CD4 + T cells from WT CD4 + T cells, but not from IL-21R Ϫ / Ϫ CD4 + T cells ( Fig. 7 ) . In addition, IL-21 -induced development of IL-21 -producing CD4 + T cells was inhibited by TGF-␤ ( Fig. 7 ) , like IL-6 -induced development was ( Fig. 3 ) . Finally, CD4 + T cells cultured in the presence of IL-6 expressed a moderate level of ROR ␥ t, but not Foxp3, T-bet, or GATA3 ( Fig. 8 ) , and exhibited a stable phenotype of IL-21 production ( Fig. 10 ) . Collectively, these results suggest that IL-21 -producing CD4 + T cells exhibit distinct characteristics from Th17 cells, that IL-21 -producing CD4 + T cells develop preferentially in an IL-6 -rich environment devoid of TGF-␤ , and that IL-21 functions as an autocrine growth factor for IL-21 -producing CD4 + T cells. but not of IL-21 -producing CD4 + T cells ( Fig. 6 ) . These fi ndings suggest that the development of IL-21 -producing CD4 + T cells, Th17 cells, and T reg cells is reciprocally regulated by the balance among IL-6 plus IL-21, TGF-␤ , and IL-2 in an environment.
Molecular mechanisms underlying the development of IL-21 -producing CD4 + T cells remain to be elucidated. We show that IL-6 and -21, both of which use STAT3 as a signaling molecule ( 11, 12, 32 ) , induce the development of IL-21 -producing CD4 + T cells ( Figs. 3 and 7 ) . It has also been reported that under Th17-polarizing conditions, IL-21 production is induced by a STAT3-dependent mechanism, but not a ROR ␥ t-dependent mechanism ( 6, 7 ), suggesting that STAT3 is critical for the development of IL-21 -producing CD4 + T cells. Because IL-6 up-regulates NFAT transcriptional activity by increasing the levels of NFATc2 ( 33 ), and because NFATc2 activates IL-21 promoter ( 34 ), it is also plausible that IL-6 -mediated activation of NFATc2 is involved in the induction of IL-21 gene expression. Because Foxp3, which is induced by TGF-␤ -mediated signaling ( 31, 35 ) , interacts with NFAT and down-regulates NFAT activity ( 36 -38 ) , TGF-␤ may suppress the development of IL-21 -producing CD4 + T cells ( Fig. 3 ) by producing Foxp3 -NFATc2 complexes.
Recently, it has been shown that IL-22 is expressed in CD4 + T cells under Th17-polarizing conditions ( 6, 39, 40 ) and that it mediates IL-23 -induced dermal infl ammation and hyperplasia of the epidermis in psoriasis ( 40 ) . Interestingly, similar to IL-21, IL-22 is induced by IL-6 but is inhibited by TGF-␤ ( 40 ). In contrast, IL-17A and -17F are expressed in the presence of IL-6 and TGF-␤ ( Fig. 3 ) ( 41, 42 ) . However, at present, it is still unknown whether IL-21 -producing CD4 + T cells do produce IL-22 together. The detailed analysis of autoimmune disease models in IL-21 -defi cient mice, IL-17A/IL-17F double-defi cient mice, and IL-17A/IL-17F/ IL-21 triple-defi cient mice may provide evidence for a nonredundant role of IL-21 -producing CD4 + T cells and IL-17A/IL-17F -producing CD4 + T cells in the pathogenesis of autoimmune diseases.
Regarding the phenotypic stability of IL-21 -producing CD4 + T cells, we found that IL-21 -producing CD4 + T cells could produce IL-21 for at least 20 d of culture ( Fig. 10 and not depicted). We also found that IL-21 -producing CD4 + T cells did not lose their ability to produce IL-21 even when they were restimulated under Th1-or Th2-polarizing conditions ( Fig. 10 ) . Interestingly, IL-21 -producing CD4 + T cells still had a potential to produce IL-4 when IL-21 -producing CD4 + T cells were restimulated under Th2-polarizing conditions, whereas IL-21 -producing CD4 + T cells did not produce IFN-␥ even when IL-21 -producing CD4 + T cells were restimulated under Th1-polarizing conditions ( Fig. 10 ) . These results indicate that IL-21 -producing CD4 + T cells exhibit a stable phenotype of IL-21 production and the silencing of IFN-␥ production. This is consistent with our previous fi nding that IL-21 inhibits IFN-␥ production in developing Th1 cells through the repression of Eomesodermin under Th17-polarizing conditions are negative for IL-17A and -17F ( Figs. 2 and 3 ) , it is suggested that IL-21 functions on Th17 cells not only as an autocrine growth factor but also as a paracrine growth factor.
Our results indicate that the developmental characteristic of IL-21 -producing CD4 + T cells is diff erent from that of Th17 cells, although both T cells require IL-6 and/or IL-21 for their development ( Figs. 3 and 7 ) ( 6 -9 ) . We demonstrate that TGF-␤ inhibits IL-6 -and IL-21 -induced development of IL-21 -producing CD4 + T cells ( Figs. 3, 4, and 7 ). In contrast, both IL-6 and TGF-␤ are required for the development of Th17 cells ( Fig. 3 ) ( 20 -22 ) . On the other hand, it has been shown that TGF-␤ induces, but IL-6 inhibits, the development of Foxp3-expressing regulatory T cells ( 20, 31 ) . In addition, IL-2 signaling inhibits the development of Th17 cells, Cell isolation. CD44 low CD25 Ϫ CD4 + naive T cells were isolated from lymph nodes of mice, as previously described ( 40 ), with minor modifi cations. In brief, CD4 + T cells were collected from lymph nodes of mice using CD4 + T cell isolation kit according to the manufacturer ' s instructions (Miltenyi Biotec). Purifi ed CD4 + T cells were stained with anti-CD44 mAb and anti-CD25 mAb, and CD44 low CD25 Ϫ cells were sorted on a FACSAria cell sorter (BD Biosciences). In the experiments shown in Fig. 1 A , Fig. 5 , and Fig. 10 , CD4 + T cells were purifi ed from lymph nodes of mice by EasySep mouse CD4 + T cell enrichment kit (StemCell Technologies, Inc.) using an automated cell separator RoboSep (StemCell Technologies, Inc.). In both cases, the resultant cells were > 98% pure CD44 low CD25 Ϫ CD4 + T cells or CD4 + T cells, respectively, by FACS analysis.
Cell culture. Naive CD4 + T cells or purifi ed CD4 + T cells were stimulated with 1 μ g/ml plate-bound anti-CD3 mAb at 0.5 -10 6 cells/ml in the presence of 1 μ g/ml anti-CD28 mAb in a 48-well plate. Where indicated, cells were cultured under either Th1-polarizing conditions (10 ng/ml IL-2, 1 ng/ml IL-12, and 10 μ g/ml anti -IL-4 mAb), Th2-polarizing conditions (10 ng/ml IL-2 and -4 and 10 μ g/ml anti -IFN-␥ mAb), or Th17-polarizing conditions (100 ng/ml IL-6, and 1 ng/ml TGF-␤ , anti -IL-4 mAb, and anti -IFN-␥ mAb). When cells were cultured for > 4 d, 20 ng/ml IL-23 was added under Th17-polarizing conditions. Where indicated, 100 ng/ml IL-6, 0.2 -5 ng/ml TGF-␤ , 10 ng/ml IL-2, 100 ng/ml IL-21, 10 μ g/ml anti -IL-2 mAb, 10 μ g/ ml anti -IL-6 mAb, or 10 μ g/ml IL-21R-Fc was added to the culture.
Retrovirus transduction. Bicistronic retrovirus vector pMX-IRES-GFP was a gift from T. Kitamura (Tokyo University, Tokyo, Japan). The IL-21 cDNA was amplifi ed by PCR and cloned into pMX-IRES-GFP (IL-21-IRES-GFP). The production of retroviruses and infection to Ba/F3 cells were performed as previously described ( 43 ) .
Intracellular cytokine analysis for IL-21. Cultured cells were washed and restimulated with 20 ng/ml PMA (Calbiochem) plus 1 μ g/ml ionomycin (Calbiochem) or plate-bound anti-CD3 mAb at 37 ° C for 5 h in the presence of 2 μ M monensin (Sigma-Aldrich). Cells were fi xed, permeabilized with Perm/Wash buff er (BD Biosciences), and incubated with IL-21R/Fc chimera for 30 min at 4 ° C. Cells were then washed with Perm/Wash buff er and stained with PE-conjugated affi nity-purifi ed F(ab ' )2 fragment of goat antihuman Fc ␥ antibody (anti-Fc PE; Jackson ImmunoResearch Laboratories) for 30 min at 4 ° C. Cells were washed twice and stained with anti-CD4 FITC and anti -IL-4 allophycocyanin (BD Biosciences), anti -IFN-␥ allophycocyanin (BD Biosciences), anti -IL-17A Alexa Fluor 647 (eBioscience), or anti -IL-17F Alexa Fluor 647 (eBioscience). Cytokine profi le on CD4 + cells was analyzed on a FACSCalibur using CellQuest Pro software (BD Biosciences). Intracellular cytokine staining for IL-4 versus IFN-␥ was performed using anti -IL-4 PE (BVD4-1D11; BD Biosciences) and anti -IFN-␥ allophycocyanin (XMG1.2, BD Biosciences) as previously described ( 43 ) .
Real-time PCR analysis. Total cellular RNA was extracted with TRIzol solution (Invitrogen). Reverse transcription was performed using an iScript cDNA synthesis kit (BioRad Laboratories). Primers and TaqMan probes for T-bet, GATA3, ROR ␥ t, Foxp3, and ␤ -actin have been previously described ( 5, 6, 41, 43 ) . Quantitative PCR was performed with an ABI PRISM 7300 sequence detection system (Applied Biosystems). The levels of T-bet, GATA3, ROR ␥ t, or Foxp3 mRNA were normalized to the levels of ␤ -actin mRNA. expression ( 43 ) . In contrast, when IL-21 -producing CD4 + T cells were restimulated under Th17-polarizing conditions, their ability to produce IL-21 was decreased and IL-17A -producing cells were increased ( Fig. 10 ) . Therefore, IL-21 -producing CD4 + T cells still have a potential for IL-4 and -17A production.
It has recently been shown that a subset of CD4 + T cells, termed follicular B helper T cells (TFH cells), produce a large amount of IL-21 ( 14 ) . TFH cells are distinguishable from other CD4 + T cell populations by several criteria, including its location in B cell follicles and the expression of chemokine receptor CXCR5, and provide a helper function to B cells ( 14 ) . In preliminary experiments, we found that CD4 + T cells cultured in the presence of IL-6 were negative for CXCR5 expression (unpublished data). Therefore, although further studies are required, it is suggested that IL-21 -producing CD4 + T cells described in the present study seem to be diff erent from TFH cells. The comparative analysis of their helper function to B cells, as well as the regulatory mechanism of IL-21 production, is required to further address the relationship between these populations.
We found that TGF-␤ -mediated suppression of IL-21 production was reduced in Smad3 Ϫ / Ϫ CD4 + T cells compared with that in WT CD4 + T cells ( Fig. 5 ) . We also found that TGF-␤ -mediated induction of Th17 cells was reduced in Smad3 Ϫ / Ϫ CD4 + T cells ( Fig. 5 ) . These results indicate that TGF-␤ -Smad3 signaling is involved not only in the induction of Th17 cell development but also in the suppression of IL-21 -producing CD4 + T cells. Interestingly, however, the inhibitory eff ects of TGF-␤ were still observed in Smad3 Ϫ / Ϫ CD4 + T cells ( Fig. 5 ) . This is consistent with a previous study showing that TGF-␤ exhibits partial eff ects on Smad3 Ϫ / Ϫ CD4 + T cells ( 44 ) . Because the molecular functions of Smad3 are somewhat overlapping to Smad2 ( 23, 24 ) , it is suggested that TGF-␤ exhibits partial eff ects on Smad3 Ϫ / Ϫ CD4 + T cells by using Smad2 as a partner of Smad4.
In conclusion, we have shown that IL-6 and -21 preferentially induce the diff erentiation of IL-21 -producing CD4 + T cells and that the diff erentiation of IL-21 -producing CD4 + T cells and Th17 cells is diff erently regulated by TGF-␤ and IL-2. Although further studies are required to address the physiological importance of IL-21 -producing CD4 + T cells in vivo, our results should add a new insight into the regulatory mechanism of helper T cell diff erentiation and the pathogenesis of autoimmune diseases.
MATERIALS AND METHODS
Mice. BALB/c mice and C57BL/6 mice were purchased from Charles River Laboratories. IL-21R -defi cient (IL-21R Ϫ / Ϫ ) mice ( 45 ) on a BALB/c background and Smad3 Ϫ / Ϫ mice ( 46 ) on a C57BL/6 background (provided by S. Honjo, M. Fujimoto, K. Kobayashi, and A. Sakamoto, Chiba University, Chiba, Japan) were described previously. All mice were housed in microisolator cages under specifi c pathogen-free conditions and animal procedures used in this study were approved by the Chiba University Animal Care and Use Committee. The assays were performed in duplicate according to the manufacturer ' s instruction. The minimum signifi cant values of these assays were 8 pg/ml of IL-4, 30 pg/ml of IFN-␥ , 17 pg/ml of IL-17A, and 63 pg/ml of IL-21.
CFSE-labeling of CD4 + T cells. Naive CD4 + T cells were labeled with 1 μ M CFSE (Invitrogen) for 10 min at 37 ° C according to the manufacturer ' s instruction.
Data analysis. Data are summarized as the mean ± the SD. The statistical analysis of the results was performed by the unpaired Student ' s t test. P values < 0.05 were considered signifi cant.
